Advertisement

Most Recent

image: Speaking of Science

Speaking of Science

By | October 1, 2013

October 2013's selection of notable quotes

0 Comments

image: Opinion: Reasons for the R&D Crisis

Opinion: Reasons for the R&D Crisis

By | September 23, 2013

Response to an opinion in The Scientist charting current pitfalls in translational research

2 Comments

image: Bacterial Quid Pro Quo

Bacterial Quid Pro Quo

By | August 19, 2013

Pseudomonas aeruginosa gather swarming speed at the expense of their ability to form biofilms in an experimental evolution setup.

0 Comments

image: Opinion: Sexual Dysfunction Matters

Opinion: Sexual Dysfunction Matters

By | August 19, 2013

Desire and arousal disorders require the biopharmaceutical industry’s attention.

7 Comments

image: Stem Cells Open Up Options

Stem Cells Open Up Options

By | August 13, 2013

Pluripotent cells can help regenerate tissues and maintain long life—and they may also help animals jumpstart drastically new lifestyles.

17 Comments

image: Week in Review, July 15–19

Week in Review, July 15–19

By | July 19, 2013

Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation

0 Comments

image: Cancer Gene Data Released

Cancer Gene Data Released

By | July 18, 2013

NCI has made public the largest-ever database of cancer-specific gene variations, paving the way for the development of new drugs and therapies.

0 Comments

image: Medical Marijuana for Kids?

Medical Marijuana for Kids?

By | July 17, 2013

The drug has brought relief to children suffering from cancer and other serious ailments, but getting access is often limited by considerable regulatory hurdles.

6 Comments

image: Week in Review, July 8–12

Week in Review, July 8–12

By | July 12, 2013

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

0 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

Advertisement

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  4. Locating Language within the Brain
Advertisement
Advertisement
LabX
LabX
RayBioTech